Adalimumab reduces pain and fatigue in ankylosing spondylitis (AS) patients - Results from the ATLAS trial

被引：0
|
作者：
Davis, J.
Luo, M. R.
Zeidler, H.
Matsumoto, A.
Dijkmans, B. A. C.
Salvarani, C.
Veys, E.
Wong, R.
Van der Heijde, D.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] HEOR, Abbott Labs, Abbott Pk, IL USA
[3] Med Hochshule, Hannover, Germany
[4] Ctr Rheumatol & Bone Res, Wheaton, IL USA
[5] Slotervaartziekenhuis, Amsterdam, Netherlands
[6] Div Rheumatol, Reggio Emilia, Italy
[7] UZ Ghent, Ghent, Belgium
[8] Abbott Labs, Parsippany, NJ USA
[9] Univ Hosp Maastricht, Maastricht, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [11] Adalimumab therapy results in significant reduction of signs and symptoms in subjects with Ankylosing spondylitis: The ATLAS trial.
    Van der Heijde, D
    Kivitz, A
    Schiff, M
    Sieper, J
    Dijkmans, B
    Braun, J
    Dougados, M
    Reveille, J
    Wong, R
    Kupper, H
    Davis, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S281 - S281
  • [12] Adalimumab is effective in reducing signs and symptoms in ankylosing spondylitis patients with total spinal ankylosis - results from ATLAS
    van der Heijde, D.
    Schiff, M.
    Braun, J.
    Borofsky, M.
    Torre, J.
    Wong, R.
    Pangan, A.
    Kupper, H.
    Collantes, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 412 - 412
  • [13] Adalimumab treatment maintains efficacy and safety in patients with ankylosing spondylitis (AS)-2-year results from ATLAS
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 412 - 412
  • [14] Adalimumab Reduces Pain, Fatigue, and Stiffness in Patients with AS: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for AS (ATLAS) (vol 35, pg 1346, 2008)
    Revicki, D. A.
    Luo, M. P.
    Wordsworth, P.
    Wong, R. L.
    Chen, N.
    Davis, J. C., Jr.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (04) : 788 - 788
  • [15] Improved physical functioning and work productivity in ankylosing spondylitis (AS) patients who were treated with adalimumab-ATLAS trial results
    Vanderheijde, D.
    Wordsworth, P.
    Luo, M. P.
    Mease, P. J.
    Reveille, J.
    Zeidler, H.
    Breban, M.
    Westhovens, R.
    Chmiel, J. J.
    Chen, N.
    Wong, R.
    Davis, J.
    RHEUMATOLOGY, 2007, 46 : I103 - I104
  • [16] Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
    van der Heijde, D.
    Schiff, M. H.
    Sieper, J.
    Kivitz, A. J.
    Wong, R. L.
    Kupper, H.
    Dijkmans, B. A. C.
    Mease, P. J.
    Davis, J. C., Jr.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 922 - 929
  • [17] Infliximab improves fatigue and pain in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial.
    van der Heijde, D
    Han, CL
    Bala, M
    Williamson, P
    Han, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S35 - S35
  • [18] Infliximab improves fatigue and pain in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)
    Van der Heijde, D
    Han, C
    Bala, M
    Williamson, P
    Han, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 318 - +
  • [19] Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.
    Van der Heijde, D
    Luo, M
    Matsumoto, A
    Mease, P
    Torre-Alonso, J
    Wordsworth, P
    Wong, R
    Davis, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S211 - S211
  • [20] Inpatient physiotherapy significantly reduces fatigue in ankylosing spondylitis patients
    Pomeroy, Emma
    Sengupta, Raj
    Mogg, Rebecca
    Richardson, Jennifer
    Gay, Lou
    Stone, Millicent A.
    RHEUMATOLOGY, 2008, 47 : II78 - II78
12345